A single‐center, retrospective analysis to compare measurement of fibrinogen using the TEG6 analyzer to the Clauss measurement in children undergoing heart surgery

Abstract

AbstractBackgroundNewer generation viscoelastic tests, TEG6s, offer point‐of‐care hemostatic therapy in adult patients. However, their efficacy in estimating fibrinogen levels in pediatric patients undergoing cardiac surgery is not well established.AimsThis study evaluates TEG6s for estimating fibrinogen levels in pediatric cardiac surgery patients and its predictive capability for post‐bypass hypofibrinogenemia.MethodsA single‐center, retrospective study on pediatric patients (under 18 years) who underwent cardiac surgery with cardiopulmonary bypass from August 2020 and November 2022. Blood samples for estimated whole blood functional fibrinogen level via TEG6s (Haemonetics Inc.) and concurrent laboratory‐measured plasma fibrinogen via von Clauss assay were collected at pre‐ and post‐cardiopulmonary bypass.ResultsPaired data for TEG6s estimated functional fibrinogen levels and plasma fibrinogen were analyzed for 432 pediatric patients pre‐bypass. It was observed that functional fibrinogen consistently overestimated plasma fibrinogen across all age groups with a mean difference of 138 mg/dL (95% confidence interval [CI]: 128–149 mg/dL). This positive bias in the pre‐bypass data was confirmed by Bland–Altman analysis. Post‐bypass, functional fibrinogen estimates were comparable to plasma fibrinogen in all patient groups with a mean difference of −6 mg/dL (95% CI: −20–8 mg/dL) except for neonates, where functional fibrinogen levels underestimated plasma fibrinogen with a mean difference of −38 mg/dL (95% CI: −64 to −12 mg/dL). The predictive accuracy of functional fibrinogen for detecting post‐bypass hypofibrinogenemia (plasma fibrinogen ≤250 mg/dL) demonstrated overall fair accuracy in all patients, indicated by an area under the curve of 0.73 (95% CI: 0.65–0.80) and good accuracy among infants, with an area under the curve of 0.80 (95% CI: 0.70–0.90). Similar performance was observed in predicting critical post‐bypass hypofibrinogenemia (plasma fibrinogen ≤200 mg/dL). Based on these analyses, optimal cutoffs for predicting post‐bypass hypofibrinogenemia were established as a functional fibrinogen level ≤270 mg/dL and MAFF ≤15 mm.ConclusionThis study demonstrates that whole blood functional fibrinogen, as estimated by TEG6s, tends to overestimate baseline plasma fibrinogen levels in pediatric age groups but aligns more accurately post‐cardiopulmonary bypass, particularly in neonates and infants, suggesting its potential as a point‐of‐care tool in pediatric cardiac surgery. However, the variability in TEG6s performance before and after bypass highlights the need for careful interpretation of its results in clinical decision‐making. Despite its contributions to understanding TEG6s in pediatric cardiac surgery, the study's design and inherent biases warrant cautious application of these findings in clinical settings.